Prevalence of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immune-deficiency virus (HIV) infections among intravenous drug users (IDUs) in the MAH-o-MEHR Harm Reduction Center of Tehran , Iran
Journal of AIDS and HIV Research · 2012
DOI: 10.5897/jahr11.039 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of AIDS and HIV Research, 2012. Verfasst von Ali Majidpour M. D.
Abstract (Originalsprache)
Intravenous drug users are considered to be at high risk of having the infections, hepatitis B virus (BBV), hepatitis C (HCV) and human immune-deficiency virus (HIV), because of their high risky behaviours especially of sharing of syringes. The objective of this study was to estimate the prevalence of BBV, HCV and HIV in intravenous drug users in a harm reduction center. A cross-sectional study was conducted in a sample of 118 cases of IDUs who were referred to Mah-o-Mehr Harm Reduction Center in Southern of Tehran in 2008. Information on sexual behaviour, socio-demographic and drug use variables were collected by means of a check list from their medical records. SPSS-15 software was used for data analysis and p-value
Zitieren
APA
D, A. M. M. (2012). Prevalence of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immune-deficiency virus (HIV) infections among intravenous drug users (IDUs) in the MAH-o-MEHR Harm Reduction Center of Tehran , Iran. Journal of AIDS and HIV Research. https://doi.org/10.5897/jahr11.039
Vancouver
D AMM. Prevalence of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immune-deficiency virus (HIV) infections among intravenous drug users (IDUs) in the MAH-o-MEHR Harm Reduction Center of Tehran , Iran. Journal of AIDS and HIV Research. 2012. doi:10.5897/jahr11.039
BibTeX
@article{D2012,
author = {D, Ali Majidpour M.},
title = {Prevalence of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immune-deficiency virus (HIV) infections among intravenous drug users (IDUs) in the MAH-o-MEHR Harm Reduction Center of Tehran , Iran},
journal = {Journal of AIDS and HIV Research},
year = {2012},
doi = {10.5897/jahr11.039}
}
EUVIMED